[Eradication therapy for the remnant stomach infected with Helicobacter pylori ].
Shimizu
Nobuyuki
N
Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo.
Kubota
Keisuke
K
Kaminishi
Michio
M
D000658:Amoxicillin / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage; D017291:Clarithromycin / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D018530:Gastric Stump; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D009853:Omeprazole / Q000008:administration & dosage*; D054328:Proton Pump Inhibitors; D013274:Stomach Neoplasms / Q000382:microbiology*; D014148:Tranexamic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; C000665:cetraxate; D014148:Tranexamic Acid; D000658:Amoxicillin; D017291:Clarithromycin; D009853:Omeprazole